Evolution of exchangeable copper and relative exchangeable copper through the course of Wilson's disease in the Long Evans Cinnamon rat

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Schmitt, Françoise ^a,b   Podevin, Guillaume ^b   Poupon, Joël ^c   Roux, Jérôme ^d   Legras, Pierre ^d   Trocello, Jean Marc ^c   Woimant, France ^c   Laprévote, Olivier ^c,e   NGuyen, Tuan Huy ^a   El Balkhi, Souleiman ^c,f  

^a Centre National de la Recherche Scientifique   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d UNIVERSITÉ D'ANGERS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UMR S 1144   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; CERULOPLASMIN OXIDASE; COPPER; EXCHANGEABLE COPPER; OXIDOREDUCTASE; RELATIVE EXCHANGEABLE COPPER; UNCLASSIFIED DRUG;

ACUTE LIVER FAILURE; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; COPPER BLOOD LEVEL; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FOOD INTAKE; HYPERBILIRUBINEMIA; LONG EVANS CINNAMON RAT; MALE; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REFERENCE VALUE; RELIABILITY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; WILSON DISEASE;

ANIMALS; CERULOPLASMIN; COPPER; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HEPATOLENTICULAR DEGENERATION; LIVER; LIVER FAILURE; LIVER FUNCTION TESTS; MALE; RATS; RATS, INBRED LEC;

EID: 84893088577     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082323     Document Type: Article

References (33)

1. Lalioti V, Sandoval I, Cassio D, Duclos-Vallee JC (2010). Molecular pathology of Wilson's disease: a brief. J Hepatol 53: 1151-1153.
2. Schilsky ML (2009) Wilson disease: current status and the future. Biochimie 91: 1278-1281.
3. Merle U, Stremmel W, Encke J (2007) Perspectives for gene therapy of Wilson disease. Curr Gene Ther 7: 217-220.
4. Medici V, Mirante VG, Fassati LR, Pompili M, Forti D, et al. (2005) Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders. Liver Transpl 11: 1056-1063.
5. Kenney SM, Cox DW (2007) Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum Mutat 28: 1171-1177.
6. El Balkhi S, Trocello JM, Poupon J, Chappuis P, Massicot F, et al. (2011) Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson's disease diagnosis. Clin Chim Acta 412: 2254-2260.
7. Venelinov TI, Beattie JH, Dainty JR, Hollands WJ, Fairweather-Tait SJ, et al. (2007) Stable isotope pilot study of exchangeable copper kinetics in human blood plasma. J Trace Elem Med Biol 21: 138-140.
8. Buckley WT, Vanderpool RA (2008) Analytical variables affecting exchangeable copper determination in blood plasma. Biometals 21: 601-612.
9. El Balkhi S, Poupon J, Trocello JM, Massicot F, Woimant F, et al. (2010) Human plasma copper proteins speciation by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry. Solutions for columns calibration by sulfur detection. Anal Chem 82: 6904-6910.
10. Kim JW, Kim JH, Seo JK, Ko JS, Chang JY, et al. (2013) Genetically confirmed Wilson disease in a 9-month old boy with elevations of aminotransferases. World J Hepatol 5: 156-159.
11. Chappuis P, Callebert J, Quignon V, Woimant F, Laplanche JL (2007) Late neurological presentations of Wilson disease patients in French population and identification of 8 novel mutations in the ATP7B gene. J Trace Elem Med Biol 21: 37-42.
12. Vonk WI, Wijmenga C, van de Sluis B (2008) Relevance of animal models for understanding mammalian copper homeostasis. Am J Clin Nutr 88: 840S-845S.
13. Yoshida MC, Masuda R, Sasaki M, Takeichi N, Kobayashi H, et al. (1987) New mutation causing hereditary hepatitis in the laboratory rat. J Hered 78: 361-365.
14. Suzuki KT, Kanno S, Misawa S, Aoki Y (1995) Copper metabolism leading to and following acute hepatitis in LEC rats. Toxicology 97: 81-92.
15. Masuda R, Yoshida MC, Sasaki M, Dempo K, Mori M (1988) Hereditary hepatitis of LEC rats is controlled by a single autosomal recessive gene. Lab Anim 22: 166-169.
16. Hayashi M, Fuse S, Endoh D, Horiguchi N, Nakayama K, et al. (2006) Accumulation of copper induces DNA strand breaks in brain cells of Long-Evans Cinnamon (LEC) rats, an animal model for human Wilson Disease. Exp Anim 55: 419-426.
17. Wu J, Forbes JR, Chen HS, Cox DW (1994) The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet 7: 541-545.
18. Siaj R, Sauer V, Stoppeler S, Spiegel HU, Kohler G, et al. (2013) Dietary copper triggers onset of fulminant hepatitis in the Long-Evans cinnamon rat model. World J Gastroenterol 18: 5542-5550.
19. Li Y, Togashi Y, Sato S, Emoto T, Kang JH, et al. (1991) Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J Clin Invest 87: 1858-1861.
20. Sone K, Maeda M, Wakabayashi K, Takeichi N, Mori M, et al. (1996) Inhibition of hereditary hepatitis and liver tumor development in Long-Evans cinnamon rats by the copper-chelating agent trientine dihydrochloride. Hepatology 23: 764-770.
21. Fong RN, Gonzalez BP, Fuentealba IC, Cherian MG (2004) Role of tumor necrosis factor-alpha in the development of spontaneous hepatic toxicity in Long-Evans Cinnamon rats. Toxicol Appl Pharmacol 200: 121-130.
22. Carstens E, Moberg GP (2000) Recognizing pain and distress in laboratory animals. ILAR J 41: 62-71.
23. Merle U, Eisenbach C, Weiss KH, Tuma S, Stremmel W (2009) Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease. J Hepatol 51: 925-930.
24. Schosinsky KH, Lehmann HP, Beeler MF (1974) Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 20: 1556-1563.
25. El Balkhi S, Poupon J, Trocello JM, Leyendecker A, Massicot F, et al. (2009) Determination of ultrafiltrable and exchangeable copper in plasma: stability and reference values in healthy subjects. Anal Bioanal Chem 394: 1477-1484.
26. Terada K, Nakako T, Yang XL, Iida M, Aiba N, et al. (1998) Restoration of holoceruloplasmin synthesis in LEC rat after infusion of recombinant adenovirus bearing WND cDNA. J Biol Chem 273: 1815-1820.
27. Kasai N, Osanai T, Miyoshi I, Kamimura E, Yoshida MC, et al. (1990) Clinicopathological studies of LEC rats with hereditary hepatitis and hepatoma in the acute phase of hepatitis. Lab Anim Sci 40: 502-505.
28. Bartee MY, Lutsenko S (2007) Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level. Biometals 20: 627-637.
29. Gray LW, Peng F, Molloy SA, Pendyala VS, Muchenditsi A, et al. (2012) Urinary copper elevation in a mouse model of Wilson's disease is a regulated process to specifically decrease the hepatic copper load. PLoS One 7: e38327.
30. Yuzbasiyan-Gurkan V, Grider A, Nostrant T, Cousins RJ, Brewer GJ (1992) Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction. J Lab Clin Med 120: 380-386.
31. Anderson LA, Hakojarvi SL, Boudreaux SK (1998) Zinc acetate treatment in Wilson's disease. Ann Pharmacother 32: 78-87.
32. Bahde R, Kapoor S, Bhargava KK, Schilsky ML, Palestro CJ, et al. (2012) PET with 64Cu-histidine for noninvasive diagnosis of biliary copper excretion in Long-Evans cinnamon rat model of Wilson disease. J Nucl Med 53: 961-968.
33. Meng Y, Miyoshi I, Hirabayashi M, Su M, Mototani Y, et al. (2004) Restoration of copper metabolism and rescue of hepatic abnormalities in LEC rats, an animal model of Wilson disease, by expression of human ATP7B gene. Biochim Biophys Acta 1690: 208-219.